| scholarly article | Q13442814 |
| P50 | author | Ralph H. Hruban | Q21063634 |
| Steven Gallinger | Q28360456 | ||
| Mariza de Andrade | Q42067404 | ||
| Kari G Rabe | Q56885267 | ||
| Michael Goggins | Q63021511 | ||
| Daniela Seminara | Q64749509 | ||
| Sapna Syngal | Q87222770 | ||
| Melissa Bondy | Q89112775 | ||
| Alison P Klein | Q89907184 | ||
| Gloria M Petersen | Q95972100 | ||
| P2093 | author name string | Henry T Lynch | |
| Jeannette F Korczak | |||
| P433 | issue | 4 | |
| P921 | main subject | pancreatic cancer | Q212961 |
| epidemiology | Q133805 | ||
| P304 | page(s) | 704-710 | |
| P577 | publication date | 2006-04-01 | |
| P1433 | published in | Cancer Epidemiology, Biomarkers & Prevention | Q326334 |
| P1476 | title | Pancreatic cancer genetic epidemiology consortium | |
| P478 | volume | 15 |
| Q35889483 | A histomorphologic comparison of familial and sporadic pancreatic cancers |
| Q33999506 | ABO blood group and other genetic variants associated with pancreatic cancer |
| Q36913473 | ATM mutations in patients with hereditary pancreatic cancer |
| Q33668716 | Absence of deleterious palladin mutations in patients with familial pancreatic cancer. |
| Q34635042 | Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. |
| Q37170192 | An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population |
| Q33656076 | Angiolymphatic invasion as a prognostic fator in resected N0 pancreatic adenocarcinoma |
| Q37633556 | Association between allergies and risk of pancreatic cancer |
| Q37659350 | Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE Study |
| Q35856675 | Association of family history of specific cancers with a younger age of onset of pancreatic adenocarcinoma |
| Q35630278 | BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study |
| Q53277551 | Carcinogenesis of pancreatic cancer: challenges, collaborations, progress. |
| Q38100643 | Clinical importance of Familial Pancreatic Cancer Registry in Japan: a report from kick-off meeting at International Symposium on Pancreas Cancer 2012. |
| Q27022338 | Collaborative cancer epidemiology in the 21st century: the model of cancer consortia |
| Q35971808 | Current knowledge on pancreatic cancer |
| Q38881654 | Diagnosis and Management of Hereditary Pancreatic Cancer |
| Q86641992 | Diagnosis and management of pancreatic cancer |
| Q64105296 | Diagnostic and therapeutic recommendations in pancreatic ductal adenocarcinoma. Recommendations of the Working Group of the Polish Pancreatic Club |
| Q37141651 | Emerging molecular biology of pancreatic cancer |
| Q57258071 | Epidemiology of pancreatic cancer in Norway: trends in incidence, basis of diagnosis and survival 1965–2007 |
| Q35444944 | Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec |
| Q36136686 | Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history |
| Q26801415 | Familial Pancreatic Adenocarcinoma |
| Q92655312 | Familial Pancreatic Cancer and Surveillance of High-Risk Individuals |
| Q35171140 | Familial and sporadic pancreatic cancer share the same molecular pathogenesis |
| Q57643835 | Familial pancreatic cancer |
| Q37918870 | Familial pancreatic cancer and hereditary syndromes: screening strategy for high-risk individuals |
| Q37644011 | Familial pancreatic cancer: Concept, management and issues. |
| Q37346042 | Familial pancreatic cancer: from genes to improved patient care |
| Q34645886 | Familial pancreatic cancer: the case for prophylactic pancreatectomy in lieu of serial screening and shared decision making |
| Q41993538 | Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma. |
| Q35951352 | Family history of pancreatic cancer in a high-risk cancer clinic: implications for risk assessment |
| Q37327141 | Fluorescence in situ hybridization to visualize genetic abnormalities in interphase cells of acinar cell carcinoma, ductal adenocarcinoma, and islet cell carcinoma of the pancreas |
| Q30512754 | Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. |
| Q37148201 | Genetic and epigenetic alterations of familial pancreatic cancers |
| Q26991615 | Genetic basis of pancreas cancer development and progression: insights from whole-exome and whole-genome sequencing |
| Q36980805 | Genetic predisposition to pancreatic cancer: a brief review |
| Q35883577 | Genetic variants in carcinogen-metabolizing enzymes, cigarette smoking and pancreatic cancer risk |
| Q36776802 | Genome-wide somatic copy number alterations in low-grade PanINs and IPMNs from individuals with a family history of pancreatic cancer |
| Q63865753 | Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter? |
| Q35692230 | Hereditary pancreatic and hepatobiliary cancers |
| Q37256603 | Identification of germline genomic copy number variation in familial pancreatic cancer |
| Q36831321 | Identifying people at a high risk of developing pancreatic cancer |
| Q33598358 | Importance of age of onset in pancreatic cancer kindreds |
| Q37480736 | Increased Prevalence of Precursor Lesions in Familial Pancreatic Cancer Patients |
| Q35945297 | Interaction of polymorphisms in mitotic regulator genes with cigarette smoking and pancreatic cancer risk |
| Q37532926 | Lifestyle, dietary, and medical history factors associated with pancreatic cancer risk in Ontario, Canada |
| Q35131081 | Linkage analysis of chromosome 4 in families with familial pancreatic cancer |
| Q34571355 | Management of pancreatic adenocarcinoma in Ontario, Canada: a population-based study using novel case ascertainment |
| Q37137953 | Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson |
| Q54135367 | Pancreatic Cancer |
| Q29622871 | Pancreatic cancer |
| Q93139016 | Pancreatic cancer and melanoma related perceptions and behaviors following disclosure of CDKN2A variant status as a research result |
| Q50680697 | Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning. |
| Q37490985 | Pancreatic cancer risk in relation to sex, lifestyle factors, and pre-diagnostic anthropometry in the Malmö Diet and Cancer Study |
| Q30490247 | Pancreatic cancer. |
| Q37589374 | Pathogenesis of pancreatic cancer: lessons from animal models |
| Q39451576 | Perioperative management of endocrine insufficiency after total pancreatectomy for neoplasia |
| Q36197062 | Preferences Regarding Return of Genomic Results to Relatives of Research Participants, Including after Participant Death: Empirical Results from a Cancer Biobank |
| Q37195077 | Prevalence and characteristics of pancreatic cancer in families with BRCA1 and BRCA2 mutations |
| Q49166530 | Prevalence of germ-line mutations in cancer genes among pancreatic cancer patients with a positive family history |
| Q35118758 | Prevalence of germline mutations in cancer predisposition genes in patients with pancreatic cancer. |
| Q64070996 | Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood |
| Q93180545 | Psychological Impact of Learning CDKN2A Variant Status as a Genetic Research Result |
| Q36451570 | Racial disparities of pancreatic cancer in Georgia: a county-wide comparison of incidence and mortality across the state, 2000-2011. |
| Q34980049 | Receptivity and Preferences in Cancer Risk Reduction Lifestyle Programs: A Survey of Colorectal Cancer Family Members |
| Q40736844 | Refinement of screening for familial pancreatic cancer. |
| Q37317310 | Risk factors and therapeutic targets in pancreatic cancer |
| Q37085786 | Risk of pancreatic cancer in breast cancer families from the breast cancer family registry |
| Q33880380 | Risk of pancreatic cancer in families with Lynch syndrome |
| Q55381776 | The benefits of modified FOLFIRINOX for advanced pancreatic cancer and its induced adverse events: a systematic review and meta-analysis. |
| Q34093776 | Therapeutic options for the management of pancreatic cancer |
Search more.